A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsinghua University; Cangzhou Central Hospital; Fuwai Yunnan Cardiovascular Hospital; Guangdon g Provincial People's Hospital; The First Affiliated Hospital of Guangzhou Medical University; First Affiliated Hospital of Harbin Medical University; Tongji Hospital; Second Hospital of Jilin University; China-Japan Union Hospital, Jilin University; Shanxi Cardiovascu lar Hospital; RenJi Hospital; Shanghai 10th People's Hospital; Beijing Anzhen Hospital; West China Hospital; Sichuan Academy of Medical Sciences; The First Affiliated Hospital of Soochow University; TEDA International Cardiovascular Hospital; Tianjin Medical University General Hospital; Renmin Hospital of Wuhan University; Wuhan University; First Affiliated Hospital Xi'an Jiaotong University; Xiam...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | China Health | Heart | Heart Disease | Heart Failure | Hospitals | Hypertension | Pulmonary Hypertension | Research